Akari Therapeutics to Present at Biotech Showcase™ 2023
NEW YORK and LONDON, Jan. 04, 2023 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today announced that Akari President and CEO Rachelle Jacques will present a company overview at Biotech Showcase 2023 on Monday, January 9, 2023 at 9 am ET. The presentation will include progress highlights from Akari’s two priority pipeline programs: a Phase 3 clinical trial of nomacopan, a novel bispecific inhibitor of complement C5 and leukotriene B4 (LTB4), for the treatment of severe pediatric hematopoietic stem cell transplant-related thrombotic microangiopathy, and a pre-clinical program investigating long-acting PAS-nomacopan as a potential treatment for geographic atrophy.
About Akari Therapeutics
Akari Therapeutics, plc (Nasdaq: AKTX) is a biotechnology company developing advanced therapies for autoimmune and inflammatory diseases. Akari's lead asset, investigational nomacopan, is a bispecific recombinant inhibitor of complement C5 activation and leukotriene B4 (LTB4) activity. Akari's pipeline includes a Phase 3 clinical trial program investigating nomacopan for severe pediatric hematopoietic stem cell transplant-related thrombotic microangiopathy (HSCT-TMA). Akari has been granted Orphan Drug, Fast Track and Rare Pediatric Disease designations from the FDA for nomacopan for the treatment of pediatric HSCT-TMA. Akari’s pipeline also includes pre-clinical research of long-acting PAS-nomacopan in geographic atrophy (GA). For more information about Akari, please visit akaritx.com.
Investor Contact:
Mike Moyer
LifeSci Advisors
(617) 308-4306
mmoyer@lifesciadvisors.com
Media Contact:
Eliza Schleifstein
Schleifstein PR
(917) 763-8106
eliza@schleifsteinpr.com
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Invitation Annual General Meeting Fenix Outdoor International AG29.3.2023 08:30:00 CEST | Press release
Invitation to the ordinary General Meeting of Shareholders of Fenix Outdoor International AG Dear Shareholder, The Board of Directors is pleased to invite you to the ordinary General Meeting concerning the financial year 2022 Date: Friday, April 21 2023, 2 pm Place: Hemvärnsgatan 9, Solna (Sweden) I. Notification Shareholders who wish to attend (in person, representation by proxy or by the Independent Proxy) the ordinary General Meeting must be recorded in the Company's share register by Thursday, 13 April 2023 at the latest and must notify the Company no later than Tuesday, 18 April 2023, 1 p.m. by telephone +46 660 26 62 00, by mail to Fenix Outdoor International AG, Hemvärnsgatan 15, 171 54 Solna (Sweden) or by e-mail info@fenixoutdoor.se of their attendance. An e-mail from the Company confirming the receipt of the notification must be presented at the entrance in order to be admitted to the ordinary General Meeting. The notification of the Shareholder must include name, personal id
Fenix Outdoor International AG Kallelse Årsstämma29.3.2023 08:30:00 CEST | Pressemelding
Kallelse till årsstämma för aktieägarei Fenix Outdoor International AG Kära aktieägare, Styrelsen inbjuder er härmed till årsstämma för räkenskapsåret 2022. Datum: Fredagen den 21 april 2023, kl. 14:00 Place: Hemvärnsgatan 9, Solna (Sverige) I. Anmälan Aktieägare som önskar att delta (personligen, genom ombud eller genom det oberoende ombudet) på årsstämman måste vara införd i bolagets aktiebok senast torsdagen den 13 april 2023 och anmäla sitt deltagande till bolaget senast tisdagen den 18 april 2023 kl. 13 00 på telefon +46 660 26 62 00, per post till Fenix Outdoor International AG, Hemvärnsgatan 15, 171 54 Solna, Sverige eller genom e-mail till info@fenixoutdoor.se. Ett e-mail från bolaget som bekräftar mottagande av anmälan, måste uppvisas vid entrén för tillträde till årsstämman. Aktieägarens anmälan måste innehålla namn, personnummer (organisationsnummer), adress, e-postadress (om tillämpligt), telefonnummer och namnet på eventuella medföljande biträden. Aktieägare som har sina a
Indberetning af insideres handel med FirstFarms A/S' aktier29.3.2023 08:17:58 CEST | pressemeddelelse
I henhold til Markedsmisbrugsforordningen art. 19, og i henhold til fuldmagt til at indberette handler for Thoraso Holding ApS, skal FirstFarms A/S hermed indberette oplysninger om ledende medarbejderes og disses nærtståendes transaktioner med FirstFarms A/S’ aktier og tilknyttede værdipapirer: Navn:Thoraso Holding ApSÅrsag:Nærtstående til bestyrelsesformand Henrik HougaardUdsteder:FirstFarms A/SLEI kode:2138007DFVFLUCCSX925Betegnelse:AktierFondskode:DK0060056166Transaktion:KøbHandelsdato:27. marts 2023Marked:OTCAntal stk.:133.891Kursværdi i DKK:11.659.228,28 Der henvises i øvrigt til vedhæftede skema. Med venlig hilsen FirstFarms A/S For yderligere information: Se venligst vores hjemmeside www.firstfarms.dk eller kontakt adm. direktør Anders H. Nørgaard på telefon 75 86 87 87. Om FirstFarms: FirstFarms er et dansk børsnoteret selskab. Vi driver FirstFarms med ansvar for de omkringliggende samfund, og vi leverer højeste kvalitet, som primært afsættes lokalt. Vi handler på nye mulighede
Report on insiders trade with FirstFarms A/S' shares29.3.2023 08:17:58 CEST | Press release
Pursuant to the Market Abuse Regulation art. 19 and according to power of attorney to report transactions on behalf of Thoraso Holding ApS, FirstFarms A/S shall hereby report transactions with FirstFarms A/S’ shares and associated securities by managerial staff and their related parties: Name:Thoraso Holding ApSReason:Closely related to chairman Henrik HougaardIssuer:FirstFarms A/SLEI code:2138007DFVFLUCCSX925Type:SharesISIN code:DK0060056166Transaction:PurchaseTrading date:27 March 2023Market:OTCNumber:133,891Market value in DKK:11,659,228.28 Reference is also made to the attached form. Best regards, FirstFarms A/S For further information: Please visit our website www.firstfarms.comor contact CEO Anders H. Nørgaard on phone +45 75 86 87 87. About FirstFarms: FirstFarms is a Danish stock exchange listed company. We operate FirstFarms with responsibility for the surrounding communities, and we deliver highest quality which is primarily sold locally. We act on new opportunities, that cre
Prospera Energy PEI ESG Initiatives Reduces Asset Retirement Liability Commendably and Gains the Principal Investors Support and Guidance to Increase ESG Efforts Effectually29.3.2023 08:01:43 CEST | Press release
CALGARY, Alberta, March 29, 2023 (GLOBE NEWSWIRE) -- Prospera Energy Inc.PEI: TSX-V; OF6A: FRA, OTC: GXRFF Approximately, two years ago Prospera was restructured to be profitable and compliant from a terminal position. Although the focus was to increase production rapidly, Prospera has commendably managed to address 400+ non-compliances and abandoned 60 wells. As a result, PEI has elevated the regulator License Liability Rating (LLR) from a deficit 0.37 past the regulator requirement (LLR=1) to surplus 1.2, erasing the liability deficit of 9+ Cdn million$ driving PEI to an asset surplus of approximately 4 Cdn million$. This is only the first-year result of a three-year liability management plan (LMR). Prospera’s commitment is to effectually implement the environmentally friendly ESG initiatives (eliminate emissions and reduce environmental footprint). Therefore, PEI has strategically engaged Philanthropist and PEI principal investor Mr. Dave Richardson and Engineering Specialist Angela